Fibrinogen human
Evicel, TachoSil, VeraSeal (fibrinogen, human) is an unknown pharmaceutical. Fibrinogen, human was first approved as Tachosil on 2004-06-08. It is used to treat afibrinogenemia and hemorrhage in the USA. It has been approved in Europe to treat hemostasis and surgical hemostasis.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
850 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hemorrhage | D006470 | MP_0001914 | R58 | 7 | 18 | 18 | 19 | 35 | 90 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 39 | 16 | 4 | 1 | 5 | 55 |
| Carcinoma | D002277 | — | C80.0 | 18 | 23 | 16 | 1 | 2 | 53 |
| Neoplasms | D009369 | — | C80 | 39 | 13 | 3 | 1 | 2 | 51 |
| Blood coagulation disorders | D001778 | EFO_0009314 | D68.9 | 3 | 4 | 3 | 8 | 29 | 44 |
| Hemostatic disorders | D020141 | — | — | 3 | 4 | 3 | 8 | 29 | 44 |
| Wounds and injuries | D014947 | — | T14.8 | 6 | 10 | 5 | 2 | 13 | 29 |
| Afibrinogenemia | D000347 | — | D68.2 | 1 | 6 | 9 | 4 | 9 | 26 |
| Hernia | D006547 | HP_0100790 | K40-K46 | 1 | — | 1 | 2 | 12 | 16 |
| Fistula | D005402 | — | — | 1 | — | 4 | 2 | 8 | 15 |
Show 68 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Recurrence | D012008 | — | — | 17 | 24 | 7 | — | 7 | 47 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 9 | 11 | 7 | — | 2 | 26 |
| Adenocarcinoma | D000230 | — | — | 6 | 11 | 9 | — | — | 22 |
| Leukemia | D007938 | — | C95 | 12 | 6 | 1 | — | 5 | 20 |
| Colorectal neoplasms | D015179 | — | — | 12 | 6 | 3 | — | — | 18 |
| Fallopian tube neoplasms | D005185 | — | — | 4 | 9 | 6 | — | 1 | 18 |
| Ovarian epithelial carcinoma | D000077216 | — | — | 5 | 7 | 6 | — | 2 | 18 |
| Pterygium | D011625 | — | H11.0 | 2 | 1 | 3 | — | 10 | 15 |
| Endometrioid carcinoma | D018269 | — | — | 3 | 8 | 5 | — | — | 14 |
| Serous cystadenocarcinoma | D018284 | — | — | 3 | 8 | 5 | — | — | 14 |
Show 132 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Covid-19 | D000086382 | — | — | 1 | 1 | — | — | 15 | 17 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 11 | 5 | — | — | 2 | 14 |
| Myeloid leukemia | D007951 | — | C92 | 11 | 4 | — | — | 2 | 13 |
| Myelodysplastic syndromes | D009190 | — | D46 | 8 | 2 | — | — | 2 | 10 |
| Syndrome | D013577 | — | — | 6 | 2 | — | — | 4 | 10 |
| Preleukemia | D011289 | — | — | 7 | 2 | — | — | 2 | 9 |
| Multiple myeloma | D009101 | — | C90.0 | 6 | 3 | — | — | 2 | 9 |
| Plasma cell neoplasms | D054219 | — | — | 5 | 3 | — | — | 2 | 8 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | 7 | 3 | — | — | 1 | 8 |
| Infections | D007239 | EFO_0000544 | — | 3 | 2 | — | — | 3 | 7 |
Show 124 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 4 | — | — | — | 2 | 6 |
| B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 3 | — | — | — | 1 | 4 |
| Thrombocytopenia | D013921 | HP_0001873 | D69.6 | 1 | — | — | — | 3 | 4 |
| B-cell lymphoma | D016393 | — | — | 3 | — | — | — | 1 | 4 |
| Neutropenia | D009503 | — | D70 | 4 | — | — | — | — | 4 |
| Myeloproliferative disorders | D009196 | — | D47.1 | 2 | — | — | — | 1 | 3 |
| Aplastic anemia | D000741 | HP_0001915 | D61.9 | 3 | — | — | — | — | 3 |
| Periodontal diseases | D010510 | — | K05.6 | 1 | — | — | — | 2 | 3 |
| Chemotherapy-induced febrile neutropenia | D064146 | — | — | 3 | — | — | — | — | 3 |
| Alzheimer disease | D000544 | EFO_0000249 | F03 | 2 | — | — | — | 1 | 3 |
Show 72 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Embolism | D004617 | — | — | — | — | — | — | 6 | 6 |
| Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | — | — | — | 5 | 5 |
| Fibrosis | D005355 | — | — | — | — | — | — | 5 | 5 |
| Pulmonary embolism | D011655 | HP_0002204 | I26 | — | — | — | — | 5 | 5 |
| Coagulation protein disorders | D020147 | — | — | — | — | — | — | 4 | 4 |
| Venous thromboembolism | D054556 | EFO_0004286 | I74 | — | — | — | — | 4 | 4 |
| Venous thrombosis | D020246 | HP_0004936 | I82.40 | — | — | — | — | 3 | 3 |
| Knee osteoarthritis | D020370 | EFO_0004616 | M17 | — | — | — | — | 3 | 3 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | — | — | 3 | 3 |
| Femoral hernia | D006550 | EFO_1001791 | K41 | — | — | — | — | 3 | 3 |
Show 166 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Fibrinogen human |
| INN | — |
| Description | Evicel, TachoSil, VeraSeal (fibrinogen, human) is an unknown pharmaceutical. Fibrinogen, human was first approved as Tachosil on 2004-06-08. It is used to treat afibrinogenemia and hemorrhage in the USA. It has been approved in Europe to treat hemostasis and surgical hemostasis. |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | CHEMBL2109072 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 31,746 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
1,704 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use